Literature DB >> 6184021

Effect of sera from patients with rheumatoid arthritis on normal lymphocytes: a possible immunoregulatory role for immune complexes.

J Highton, G S Panayi, P Shepherd, P Wooley.   

Abstract

The ability of rheumatoid sera to support concanavalin-A transformation of normal lymphocytes was inversely related to serum C1q binding activity. When C1q binding activity of the sera was removed by absorption with staphylococcal protein A, subsequent lymphocyte response increased to the level found in immune-complex negative sera. Gel filtration of a small number of sera suggested that the suppressive material had a molecular weight in the range 1.8-4.9 x 10(5) daltons. Aggregated human gammaglobulin suppressed con-A transformation of normal lymphocytes in a dose-dependent fashion. These results suggest that immune complexes present in rheumatoid sera can suppress lymphocyte responsiveness. The relevance of this observation to be clinical features of rheumatoid arthritis is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6184021      PMCID: PMC1000985          DOI: 10.1136/ard.41.6.563

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Extracorporeal irradiation of thoracic duct lymph as immunosuppressive treatment in rheumatoid arthritis.

Authors:  J Edgren; M Klockars; T Weber; A Wangel; B Linström; K Stenstrand; T Pettersson; H Riska; A Kajander; O Wegelius
Journal:  Scand J Rheumatol       Date:  1976       Impact factor: 3.641

2.  Early joint lesions of rheumatoid arthritis; report of eight cases, with knee biopsies of lesions of less than one year's duration.

Authors:  J P KULKA; D BOCKING; M W ROPES; W BAUER
Journal:  AMA Arch Pathol       Date:  1955-02

3.  The role of the lymphocyte and its products in the propagation of joint disease.

Authors:  C M Pearson; H E Paulus; H I Machleder
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

4.  Detection of IgG rheumatoid factor by concanavalin A treatment and complement fixation with IgG rheumatoid factor.

Authors:  K Tanimoto; T Moritoh; T Azuma; Y Horiuchi
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Synovitis of recent onset. A clinicopathologic study during the first month of disease.

Authors:  H R Schumacher; R C Kitridou
Journal:  Arthritis Rheum       Date:  1972 Sep-Oct

7.  Generation of suppressor cells by aggregated human globulin.

Authors:  J P Antel; M E Medof; J J Oger; H H Kuo; B G Arnason
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

8.  The use of concanavalin A to measure acute phase proteins by laser nephelometry.

Authors:  C Warren; J Whicher; J Kohn
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

10.  Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A.

Authors:  J S McDougal; P B Redecha; R D Inman; C L Christian
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.